Fig. 5.

Progression free survival (PFS) under the therapeutic regimen directly preceding the molecular therapies (left) versus PFS under the molecularly targeted therapy (right). Colors indicating the response at 3 months follow-up

Progression free survival (PFS) under the therapeutic regimen directly preceding the molecular therapies (left) versus PFS under the molecularly targeted therapy (right). Colors indicating the response at 3 months follow-up